Dinesh V. Ph D. Patel, President and CEO at Protagonist Therapeutics, Inc (PTGX), sold 185,520 shares at $46.25 ($8.4M) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Open-market sale of $8.4M PTGX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,000 | $0 | 0.0% |
| 2 | $46.96 | 78,520 | $3.7M | 44.1% |
| 3 | $46.96 | 78,520 | $3.7M | 44.1% |
| 4 | $46.25 | 21,480 | $993K | 11.9% |
| Total | $45.11 avg | 185,520 | $8.4M | 100% |
| Filing → |
| PTGX | SELL | 2026-03-25 | $5.5M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $4.1M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $2.8M | — | Filing → |